Insider Transactions in Q1 2021 at Signify Health, Inc. (SGFY)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Stephen F Wiggins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
178,319
+1.12%
|
$356,638
$2.01 P/Share
|
|
Feb 16
2021
|
Laurel Douty EVP, Clinic. Ops, Care Srvces |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$240,000
$24.0 P/Share
|
|
Feb 16
2021
|
Matthew S. Holt Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,916
+50.0%
|
-
|
|
Feb 16
2021
|
Albert A Notini Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,916
+50.0%
|
-
|
|
Feb 16
2021
|
Kyle B. Peterson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,916
+50.0%
|
-
|
|
Feb 16
2021
|
Taj J. Clayton Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,916
+50.0%
|
-
|
|
Feb 16
2021
|
Kevin M Mcnamara Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,916
+50.0%
|
-
|
|
Feb 16
2021
|
Brandon H Hull Director |
BUY
Open market or private purchase
|
Direct |
13,900
+38.92%
|
$333,600
$24.0 P/Share
|
|
Feb 16
2021
|
Brandon H Hull Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,916
+50.0%
|
-
|
|
Feb 16
2021
|
Laurence Michael Orton Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
5,200
+50.0%
|
$124,800
$24.0 P/Share
|
|
Feb 16
2021
|
Adam Mc Ananey General Counsel and Secretary |
BUY
Open market or private purchase
|
Direct |
13,900
+26.98%
|
$333,600
$24.0 P/Share
|
|
Feb 16
2021
|
David Pierre Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
13,200
+50.0%
|
$316,800
$24.0 P/Share
|
|
Feb 16
2021
|
Vivian E. Riefberg Director |
BUY
Open market or private purchase
|
Direct |
13,900
+38.92%
|
$333,600
$24.0 P/Share
|
|
Feb 16
2021
|
Vivian E. Riefberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,916
+50.0%
|
-
|
|
Feb 16
2021
|
Marc D Rothman Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$24,000
$24.0 P/Share
|
|
Feb 16
2021
|
Steve Senneff Pres. Chief Fin. & Admin. Off. |
BUY
Open market or private purchase
|
Direct |
13,900
+11.03%
|
$333,600
$24.0 P/Share
|
|
Feb 16
2021
|
Stephen F Wiggins Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,916
+50.0%
|
-
|
|
Feb 16
2021
|
Bradford Kyle Armbrester Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
13,900
+50.0%
|
$333,600
$24.0 P/Share
|
|
Feb 16
2021
|
New Mountain Capital, L.L.C. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
23,748
+50.0%
|
-
|
|
Feb 12
2021
|
Peter Boumenot Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
186,038
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Taj J. Clayton Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,173
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Josh Builder Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
145,011
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Laurel Douty EVP, Clinic. Ops, Care Srvces |
BUY
Grant, award, or other acquisition
|
Direct |
145,042
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Kevin M Mcnamara Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,260,850
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Brandon H Hull Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,030,500
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Adam Mc Ananey General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
24,173
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Adam Mc Ananey General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
23,728
+50.0%
|
-
|
|
Feb 12
2021
|
David Pierre Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
772,875
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Vivian E. Riefberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,173
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Marc D Rothman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,837
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Steve Senneff Pres. Chief Fin. & Admin. Off. |
BUY
Grant, award, or other acquisition
|
Direct |
506,975
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Steve Senneff Pres. Chief Fin. & Admin. Off. |
BUY
Grant, award, or other acquisition
|
Direct |
98,214
+50.0%
|
-
|
|
Feb 12
2021
|
Stephen F Wiggins Director |
BUY
Grant, award, or other acquisition
|
Indirect |
4,048
+50.0%
|
-
|
|
Feb 12
2021
|
Stephen F Wiggins Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,697,691
+50.0%
|
-
|
|
Feb 12
2021
|
Bradford Kyle Armbrester Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
2,304,479
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Bradford Kyle Armbrester Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,686,599
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
Bradford Kyle Armbrester Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
100
-100.0%
|
$100
$1.0 P/Share
|
|
Feb 12
2021
|
New Mountain Capital, L.L.C. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
42,905,113
+50.0%
|
$0
$0.01 P/Share
|
|
Feb 12
2021
|
New Mountain Capital, L.L.C. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
96,709,693
+50.0%
|
-
|